Nuclear cardiology update

Radiologic Clinics of North America

Volumn 39, Issue 5, 2001, Pages 931-946

  Cerqueira, Manuel D ^b   Lawrence, Andrew ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CAFFEINE; DIPYRIDAMOLE; DOBUTAMINE; FURIFOSMIN TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLXANTHINE; RADIOPHARMACEUTICAL AGENT; TEBOROXIME TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; VASODILATOR AGENT;

ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; EXERCISE TEST; HEADACHE; HEART EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE WALL MOTION; HEMODYNAMIC PARAMETERS; HUMAN; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; REVIEW; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASODILATATION;

EID: 0034813916     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70321-3     Document Type: Article

References (44)

1. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease
2. The cardiac effects of adenosine
3. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study
4. Nuclear Cardiology
5. Pharmacologic stress versus maximal-exercise stress for perfusion imaging: Which, when, and why?
6. The user-friendly nuclear cardiology report: What needs to be considered and what is included
7. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry
8. Gating provides improved accuracy for differentiating artifacts from true lesions in equivocal fixed defects on technetium 99m tetrofosmin perfusion SPECT
9. Electrocardiographically gated myocardial perfusion SPECT: Technical principles and quality control considerations
10. Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging
11. Updated imaging guidelines for nuclear cardiology procedures, Part 1
12. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT
13. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact
14. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium
15. Left ventricular ejection fraction and volumes from gated single photon emission tomographic myocardial perfusion images: Comparison between two algorithms working in three-dimensional space
16. Left ventricular ejection fraction from gated SPECT myocardial perfusion studies: A method based on the radial distribution of count rate density across the myocardial wall
17. Gated SPECT myocardial perfusion acquisition within 5 minutes using focusing collimators and a three-head gamma camera
18. Cardiofocal collimators for gated single-photon emission tomographic myocardial perfusion imaging
19. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: Intraindividual comparison with technetium-99m-sestamibi
20. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
21. Comparative myocardial uptake of technetium-99m sestamibi and technetium-99m tetrofosmin one hour after stress injection
22. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction
23. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing
24. Diagnostic value of a new myocardial perfusion agent, teboroxime (SO 30,217), utilizing a rapid planar imaging protocol: Preliminary results
25. Safety of intravenous dipyridamole for stress testing with thallium imaging
26. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: Analysis of 461 patients
27. Pharmacologic stress testing: Mechanism of action, hemodynamic responses, and results in detection of coronary artery disease
28. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms
29. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system: Multicenter trial for evaluation of safety and diagnostic accuracy
30. Rapid data acquisition protocol in ECG-gated myocardial perfusion SPECT with Tc 99m-tetrofosmin
31. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study
32. Combined rest thallium-201/stress technetium-99m-tetrofosmin SPECT: Feasibility and diagnostic accuracy of a 90-minute protocol
33. Assessment of left ventricular volume using ECG-gated SPECT with technetium-99m-MIBI and technetium-99m-tetrofosmin
34. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease
35. Functional imaging of gated Tc 99m tetrofosmin study as a simple method to quantify ventricular wall motion
36. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin
37. Imaging guidelines for nuclear cardiology procedures, part 2
38. The safety of intravenous dipyridamole thallium myocardial perfusion imaging
39. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis: Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects
40. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99mTc-tetrofosmin single-photon emission tomography and magnetic resonance imaging
41. New Radiotracers in Cardiac Imaging
42. Dobutamine myocardial perfusion imaging
43. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: Can we use the same reference data base?
44. Exercise 201Tl/rest 99Tcm-tetrofosmin myocardial perfusion imaging: A convenient protocol for the assessment of coronary disease